In a meta-analysis of studies with short-term follow-up, Peng and colleagues (2019) examined the efficacy of magnetic stimulation (MS) in female patients with SUI by investigating peer-reviewed RCTs. PubMed, Embase, and Cochrane library were retrieved for any peer-reviewed original articles in English. Databases were searched up to July 2018. Included studies examined effects of MS on SUI. The data were analyzed by review manager 5.3 software (Cochrane Collaboration, Oxford, UK). A total of 4 studies involving 232 patients were identified and included in present meta-analysis. Compared with the sham stimulation, the MS group had statistically significantly fewer leaks/3 days (MD = -1.42; 95 % CI: -2.42 to -0.59; p = 0.007), less urine loss on pad test (g/24 hours) (MD = -4.99; 95 % CI: -8.46 to -1.53; p = 0.005), higher QoL scores (MD = 0.42; 95 % CI: 0.02 to 0.82; p = 0.009), and lower ICIQ scores (MD = -4.60; 95 % CI: -5.02 to -4.19; p < 0.001). MS presented higher cure or improvement rate, with a statistically significant improvement in UDI and IIQ-SF scores compared to sham stimulation. No MS-related AEs were reported in study. The authors concluded that MS led to an improvement in SUI without any reported safety concerns and an improvement in patient QoL; however, the long-term outcome of this technique remains unclear and is the subject of ongoing research.